{"id":11480,"date":"2026-02-18T09:19:31","date_gmt":"2026-02-18T09:19:31","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/11480\/"},"modified":"2026-02-18T09:19:31","modified_gmt":"2026-02-18T09:19:31","slug":"ubs-reaffirmed-buy-rating-on-veracyte-vcyt-after-strong-q4-testing-revenue-4","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/11480\/","title":{"rendered":"UBS Reaffirmed Buy Rating on Veracyte (VCYT) After Strong Q4 Testing Revenue"},"content":{"rendered":"\n

Veracyte, Inc. (NASDAQ:VCYT<\/a>) ranks among the best innovative stocks to buy according to Wall Street analysts<\/a>. On January 12, UBS reaffirmed its Buy rating for Veracyte, Inc. (NASDAQ:VCYT) alongside a price target of $48. Analyst Lu Li retained a favorable outlook after Veracyte\u2019s Q4 testing revenue exceeded expectations, which the company attributed mostly to higher average selling prices and prior-period collections rather than volume growth in Decipher tests.<\/p>\n

\"\" <\/p>\n

Veracyte\u2019s 2026 testing revenue projections exceeded street expectations, and the company kept its projected adjusted EBITDA margin of 25%, up from about 21% in 2024, which UBS deems favorable for the stock\u2019s outlook.<\/p>\n

The firm also noted potential gains from new product contributions, suggesting that the company\u2019s current revenue projection does not fully account for all growth prospects.<\/p>\n

Overall, Veracyte, Inc. (NASDAQ:VCYT) reported preliminary fourth-quarter 2025 revenue of $138-140 million, representing a 16%-18% year-over-year increase that exceeded the consensus forecast of $132 million.<\/p>\n

Veracyte, Inc. (NASDAQ:VCYT) is a genomic diagnostics company that develops tests to improve diagnosis and treatment decisions for thyroid, lung, and other cancers, as well as autoimmune diseases.<\/p>\n

While we acknowledge the potential of VCYT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the\u00a0best short-term AI stock<\/a>.<\/p>\n

READ NEXT:\u00a010 Best Magic Formula Stocks for 2025<\/a>\u00a0and\u00a010 Best Retirement Stocks to Buy According to Hedge Funds<\/a>.<\/p>\n

Disclosure: None. This article is originally published at\u00a0Insider Monkey<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Veracyte, Inc. (NASDAQ:VCYT) ranks among the best innovative stocks to buy according to Wall Street analysts. On January…\n","protected":false},"author":2,"featured_media":7592,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[129],"tags":[5992,2039,5994,5991,5993,223,5990],"class_list":{"0":"post-11480","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ubs","8":"tag-favorable-outlook","9":"tag-inc","10":"tag-lu-li","11":"tag-revenue-projection","12":"tag-revenue-projections","13":"tag-ubs","14":"tag-veracyte"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/11480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=11480"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/11480\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/7592"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=11480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=11480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=11480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}